Relative potency of different generic brands of Piperacillin-Tazobactam: Implications for public health

J Infect Public Health. 2017 Nov-Dec;10(6):901-902. doi: 10.1016/j.jiph.2016.10.005. Epub 2017 Feb 10.

Authors

Parijat Das¹, Rajkumar Mahto¹, Gaurav Goel¹, Mammen Chandy², Sanjay Bhattacharya³

Affiliations

¹ Department of Microbiology, Tata Medical Center, Kolkata, India.
² Department of Clinical Hematology, Tata Medical Center, Kolkata, India.
³ Department of Microbiology, Tata Medical Center, South Lab, 14 Major Arterial Road (E-W), New Town, Rajarhat, Kolkata 700 156, India. Electronic address: Sanjay.Bhattacharya@tmckolkata.com.

PMID: 28209322
DOI: 10.1016/j.jiph.2016.10.005

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / standards*
Drugs, Generic / standards*
India
Klebsiella pneumoniae / drug effects
Microbial Sensitivity Tests
Piperacillin / pharmacology
Piperacillin / standards*
Public Health*
Tazobactam / pharmacology
Tazobactam / standards*

Substances

Anti-Bacterial Agents
Drugs, Generic
Tazobactam
Piperacillin